← Leaderboards

Sharon M Moe

Indiana University Indianapolis

Google Scholar ↗PubMed ↗ORCID ↗

$24,308,038

Attributed

$47,240,461

Total exposure

18

Grants

16

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $8.2M · FY2006–25

$10M$7.5M$5M$2.5M$0

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$53,520,262 · 17

FDA$592,511 · 1

VA$0 · 1

By mechanism

UL1$16,581,057 · 1

UM1$16,320,212 · 1

R01$9,834,354 · 7

P30$8,388,254 · 4

T32$1,346,070 · 1

K24$1,200,233 · 1

Top collaborators

Most similar at Indiana University Indianapolis

Same institution · by research overlap

Kenneth E White$12,659,578
Sarah Elizabeth Wiehe$24,116,792

Others in their field

Top investigators on “Indiana”

Olaf Schneewind · University Of California Los Angeles$87,583,896
Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$73,204,296
Anantha Shekhar · Indiana Univ-Purdue Univ At Indianapolis$52,198,350
James E Crowe · Vanderbilt University Medical Center$44,564,247
Bradley F Boeve · Mayo Clinic Rochester$44,410,531
Elizabeth Baseler · Leidos Biomedical Research, Inc.$40,046,035

Research focus

IndianaClinical ResearchBoneResearch PersonnelPhenotypeFundingInnovationKidney DiseasesTrainingChronic Kidney FailureMineralsResourcesUnited States National Institutes Of HealthFunctional DisorderPathogenesisUniversitiesCommunitiesPreventionMusculoskeletal DiseasesTranslational ResearchServicesLinkElectronic Health RecordCommunication

Grant awards (83)

Indiana Clinical and Translational Sciences Institute$5,260,393

UM1 · FY2025 · TR · contact PI

Uremic Toxins and Cardiovascular Disease$709,715

R01 · FY2025 · HL · contact PI

Indiana Core Center for Clinical Research in Musculoskeletal Health$649,835

P30 · FY2025 · AR · contact PI

Uremic toxins and osteocyte dysfunction in CKD$550,066

R01 · FY2025 · DK · contact PI

Precision medicine approaches to renal osteodystrophy$500,152

R01 · FY2025 · DK

Administration Core$165,216

P30 · FY2025 · AR · contact PI

Indiana Clinical and Translational Sciences Institute$158,500

UM1 · FY2025 · TR · contact PI

Indiana Clinical and Translational Sciences Institute$5,426,574

UM1 · FY2024 · TR · contact PI

Indiana Core Center for Clinical Research in Musculoskeletal Health$753,045

P30 · FY2024 · AR · contact PI

Uremic Toxins and Cardiovascular Disease$718,091

R01 · FY2024 · HL · contact PI

Uremic toxins and osteocyte dysfunction in CKD$598,846

R01 · FY2024 · DK · contact PI

Precision medicine approaches to renal osteodystrophy$517,994

R01 · FY2024 · DK

Administration Core$183,572

P30 · FY2024 · AR · contact PI

Indiana Clinical and Translational Sciences Institute$5,474,745

UM1 · FY2023 · TR · contact PI

Indiana Core Center for Clinical Research in Musculoskeletal Health$770,161

P30 · FY2023 · AR · contact PI

Precision medicine approaches to renal osteodystrophy$550,039

R01 · FY2023 · DK

Indiana University Kidney Training Program (IU-KTP)$319,694

T32 · FY2023 · DK · contact PI

Administration Core$183,572

P30 · FY2023 · AR · contact PI

2023 Physiology, Biology and Pathology of Phosphate GRC$5,000

R13 · FY2023 · DK · contact PI

Indiana Clinical and Translational Sciences Institute$5,402,523

UL1 · FY2022 · TR · contact PI

Indiana Core Center for Clinical Research in Musculoskeletal Health$786,796

P30 · FY2022 · AR · contact PI

Precision medicine approaches to renal osteodystrophy$581,086

R01 · FY2022 · DK

Indiana University Kidney Training Program (IU-KTP)$287,083

T32 · FY2022 · DK · contact PI

Administration Core$183,572

P30 · FY2022 · AR · contact PI

Indiana Clinical and Translational Sciences Institute$5,597,901

UL1 · FY2021 · TR · contact PI

Indiana Core Center for Clinical Research in Musculoskeletal Health$776,745

P30 · FY2021 · AR · contact PI

Indiana University Kidney Training Program (IU-KTP)$286,592

T32 · FY2021 · DK · contact PI

Administrative Core$160,002

P30 · FY2021 · AR · contact PI

Indiana Clinical and Translational Sciences Institute$5,264,717

UL1 · FY2020 · TR · contact PI

Indiana Core Center for Clinical Research in Musculoskeletal Health$776,745

P30 · FY2020 · AR · contact PI

Indiana University Kidney Training Program (IU-KTP)$301,621

T32 · FY2020 · DK · contact PI

Indiana Clinical and Translational Sciences Institute$201,078

UL1 · FY2020 · TR · contact PI

Administrative Core$160,002

P30 · FY2020 · AR · contact PI

Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval Process$114,838

UL1 · FY2020 · TR · contact PI

The mechanism of uremia induced vascular calcification$0

I01 · FY2020 · VA · contact PI

Indiana Core Center for Clinical Research in Musculoskeletal Health$776,745

P30 · FY2019 · AR · contact PI

Pathogenesis of compromised bone quality and mechanics in chronic kidney disease.$431,326

R01 · FY2019 · DK · contact PI

Administrative Core$160,002

P30 · FY2019 · AR · contact PI

Indiana University Kidney Training Program (IU-KTP)$151,080

T32 · FY2019 · DK · contact PI

The mechanism of uremia induced vascular calcification$0

I01 · FY2019 · VA · contact PI

Indiana Core Center for Clinical Research in Musculoskeletal Health$776,745

P30 · FY2018 · AR · contact PI

Pathogenesis of compromised bone quality and mechanics in chronic kidney disease.$461,139

R01 · FY2018 · DK · contact PI

Administrative Core$160,002

P30 · FY2018 · AR · contact PI

The mechanism of uremia induced vascular calcification$0

I01 · FY2018 · VA · contact PI

Indiana Core Center for Clinical Research in Musculoskeletal Health$805,495

P30 · FY2017 · AR · contact PI

Pathogenesis of compromised bone quality and mechanics in chronic kidney disease.$470,578

R01 · FY2017 · DK · contact PI

IND 117464 Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease$194,799

R01 · FY2017 · FD · contact PI

Administrative Core$160,002

P30 · FY2017 · AR · contact PI

The mechanism of uremia induced vascular calcification$0

I01 · FY2017 · VA · contact PI

Pathogenesis of compromised bone quality and mechanics in chronic kidney disease.$471,810

R01 · FY2016 · DK · contact PI

Genetic risks for cardiovascular events in ESRD patients from the EVOLVE study.$341,829

R01 · FY2016 · DK · contact PI

IND 117464 Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease$198,120

R01 · FY2016 · FD · contact PI

Genetic risks for cardiovascular events in ESRD patients from the EVOLVE study.$341,773

R01 · FY2015 · DK · contact PI

IND 117464 Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease$199,592

R01 · FY2015 · FD · contact PI

The Mechanism of Uremia Induced Vascular Calcification$0

I01 · FY2015 · VA · contact PI

Genetic risks for cardiovascular events in ESRD patients from the EVOLVE study.$351,886

R01 · FY2014 · DK · contact PI

Bisphosphonates in the treatment of chronic kidney disease-mineral bone disease$325,987

R01 · FY2014 · AR · contact PI

The Mechanism of Uremia Induced Vascular Calcification$0

I01 · FY2014 · VA · contact PI

Bisphosphonates in the treatment of chronic kidney disease-mineral bone disease$316,008

R01 · FY2013 · AR · contact PI

The Mechanism of Uremia Induced Vascular Calcification$0

I01 · FY2013 · VA · contact PI

Bisphosphonates in the treatment of chronic kidney disease-mineral bone disease$332,640

R01 · FY2012 · AR · contact PI

The Mechanism of Uremia Induced Vascular Calcification$0

I01 · FY2012 · VA · contact PI

Randomized trial of active vitamin D, cholecalciferol and placebo for CKD-MBD$437,593

U34 · FY2011 · DK · contact PI

Bisphosphonates in the treatment of chronic kidney disease-mineral bone disease$332,640

R01 · FY2011 · AR · contact PI

Bisphosphonates in the treatment of chronic kidney disease-mineral bone disease$338,238

R01 · FY2010 · AR · contact PI

Musculoskeletal Disorder in Dialysis Patients$126,412

K24 · FY2010 · DK · contact PI

Musculoskeletal Disorder in Dialysis Patients$49,917

K24 · FY2010 · DK · contact PI

Musculoskeletal Disorder in Dialysis Patients$124,305

K24 · FY2009 · DK · contact PI

Musculoskeletal Disorder in Dialysis Patients$122,623

K24 · FY2008 · DK · contact PI

Musculoskeletal Disorder in Dialysis Patients$121,096

K24 · FY2007 · DK · contact PI

Musculoskeletal Disorder in Dialysis Patients$119,142

K24 · FY2006 · DK · contact PI

MUSCULOSKELETAL DISORDERS IN DIALYSIS PATIENTS$114,024

K24 · FY2004 · DK

MUSCULOSKELETAL DISORDERS IN DIALYSIS PATIENTS$111,699

K24 · FY2003 · DK

MUSCULOSKELETAL DISORDERS IN DIALYSIS PATIENTS$109,442

K24 · FY2002 · DK

CALCIMIMETIC AGENT IN RENAL DISEASE HYPERPARATHYROIDISM$0

M01 · FY2002 · RR

MUSCULOSKELETAL DISORDERS IN DIALYSIS PATIENTS$101,850

K24 · FY2001 · DK

CALCIMIMETIC AGENT IN RENAL DISEASE HYPERPARATHYROIDISM$0

M01 · FY2001 · RR

MUSCULOSKELETAL DISORDERS IN DIALYSIS PATIENTS$99,723

K24 · FY2000 · DK

CALCIMIMETIC AGENT IN RENAL DISEASE HYPERPARATHYROIDISM$0

M01 · FY2000 · RR

CALCIMIMETIC AGENT IN RENAL DISEASE HYPERPARATHYROIDISM$0

M01 · FY2000 · RR

CALCIMIMETIC AGENT IN RENAL DISEASE HYPERPARATHYROIDISM$0

M01 · FY2000 · RR

CALCIMIMETIC AGENT IN RENAL DISEASE HYPERPARATHYROIDISM$0

M01 · FY2000 · RR

CALCIMIMETIC AGENT IN RENAL DISEASE HYPERPARATHYROIDISM$0

M01 · FY2000 · RR